• Теги
    • избранные теги
    • Компании545
      • Показать ещё
      Разное135
      • Показать ещё
      Страны / Регионы90
      • Показать ещё
      Формат2
      Показатели4
      Международные организации12
      • Показать ещё
      Издания10
      • Показать ещё
      Сферы1
      Люди2
St Jude Medical
02 декабря, 22:46

MedTech Sails Through Macro Woes: Stocks in Focus

MedTech Sails Through Macro Woes: Stocks in Focus

24 ноября, 16:34

ЕК одобрила сделку между Abbott и St. Jude

В среду, 23 ноября, Европейская комиссия одобрила $25-миллиардную сделку по приобретению американской фармацевтической компанией Abbott Laboratories производителя медицинских устройств St. Jude Medical. Стоит отметить, что ЕК одобрила сделку при условии, что Abbott выведет два актива в сфере лечения сердечно-сосудистой системы.

24 ноября, 11:50

ЕК одобрила сделку между Abbott и St. Jude

В среду, 23 ноября, Европейская комиссия одобрила $25-миллиардную сделку по приобретению американской фармацевтической компанией Abbott Laboratories производителя медицинских устройств St. Jude Medical. Стоит отметить, что ЕК одобрила сделку при условии, что Abbott выведет два актива в сфере лечения сердечно-сосудистой системы.

Выбор редакции
17 ноября, 15:22

St. Jude Medical's MOMENTUM 3 IDE Study Results Encourage

St. Jude Medical Inc. (STJ) recently announced positive results from its MOMENTUM 3 U.S. IDE Clinical Study, which compared the HeartMate 3 Left Ventricular Assist System (LVAS) to the HeartMate II LVAS.

16 ноября, 19:28

Антимонопольные органы ЕС могут одобрить сделку между Abbott Laboratories и St. Jude Medical

Как заявляют осведомленные источники, антимонопольные органы ЕС могут в ближайшее время одобрить $25-миллиардную сделку по слиянию американской фармацевтической компании Abbott Laboratories и американского производителя медицинского оборудования St. Jude Medical. Сообщается, что европейский регулятор должен принять решение до 23 ноября.

16 ноября, 12:43

Антимонопольные органы ЕС могут одобрить сделку между Abbott Laboratories и St. Jude Medical

Как заявляют осведомленные источники, антимонопольные органы ЕС могут в ближайшее время одобрить $25-миллиардную сделку по слиянию американской фармацевтической компании Abbott Laboratories и американского производителя медицинского оборудования St. Jude Medical. Сообщается, что европейский регулятор должен принять решение до 23 ноября.

16 ноября, 07:00

The True Story of the Maverick Who Pioneered Open Heart Surgery (2000)

Clarence Walton "Walt" Lillehei (October 23, 1918 – July 5, 1999), was an American surgeon who pioneered open-heart surgery, as well as numerous techniques, equipment and prostheses for cardiothoracic surgery. About the book: https://www.amazon.com/gp/product/0609807242/ref=as_li_tl?ie=UTF8&camp=1789&creative=9325&creativeASIN=0609807242&linkCode=as2&tag=mg03-20&linkId=27c0a0d36964b7af1fb4bfcf0d3a3054 A Department of Surgery professor at the University of Minnesota from 1951 to 1967, Lillehei participated in the world's first successful open-heart operation using hypothermia. In 1944, Alfred Blalock at Johns Hopkins University had begun successfully performing surgery on the great vessels around the heart to relieve the symptoms of tetralogy of Fallot, demonstrating that heart surgery could be possible. Young and brash, Lillehei completed, at age 35, the first successful surgical repair of the heart on September 2, 1952. That historic operation, using hypothermia, was led by his longtime friend and colleague, Dr. F. John Lewis.[4] Hypothermia, however, only gave a brief window (up to 10 minutes) during which surgery could be performed and was therefore not suited for complex congenital defects within the heart. To resolve this problem, Lillehei performed surgeries using cross-circulation, in which a donor was hooked up nearby to take up the pumping and oxygenation functions of the patient as he was being operated on. Using this technique, Lillehei led the team that performed successful repair of a ventricular septal defect on March 26, 1954. Although the repair was successful, the patient, 13-month-old Gregory Glidden, died 11 days later of suspected pneumonia. Lillehei and his team continued to use cross-circulation for a total of 44 open-heart operations in the following year, of which 32 patients survived. These surgeries included the first repairs of the atrioventricular canal and tetralogy of Fallot. In July of that year, a successful operation was performed on patient Michael Eugene Shaw (aka Mike Shaw) of Litchfield, Minnesota.[5] Lillehei was cooperated with Professor Moshe Gueron and Professor Morris J. Levy, who were both considered among "The Cardiology Founders of Israel" by doing the first Cardiac Puncture Catheterization research which was experienced in 80 patients during 1964.[6] In 1958, Lillehei was responsible for the world's first use of a small, external, portable, battery-powered pacemaker. It was invented at his behest by Earl Bakken, whose then-small company, Medtronic, designed and repaired electronics for the University of Minnesota hospital. After the introduction of the first widely used prosthetic heart valves by Albert Starr in 1961, Lillehei also developed and implanted several innovative designs: the Lillehei-Nakib toroidal disc (1966), the Lillehei-Kaster pivoting disc (1967), and the Kalke-Lillehei rigid bileaflet prosthesis (1968). [7] A dedicated educator, Lillehei trained more than 150 cardiac surgeons from 40 nations, including Norman Shumway and Christiaan Barnard, who formed half of the quartet which pioneered heart transplantation (the others being Richard Lower and Adrian Kantrowitz).[8] In 1967, he was appointed Lewis Atterbury Stimson professor and chairman of the surgery department at Cornell Medical Center, New York. He returned to St. Paul, Minnesota, in 1975, where he became the director of medical affairs at St. Jude Medical, Inc. He was also named a clinical professor in the Department of Surgery at the University of Minnesota. https://en.wikipedia.org/wiki/C._Walton_Lillehei

24 октября, 20:38

St. Jude Heart Devices Can Be Hacked, Experts Say

(Reuters) - Short-selling firm Muddy Waters said in a legal brief filed on Monday that outside cyber security experts it hired have validated its claim that St. Jude Medical Inc cardiac implants are vulnerable to potentially life-threatening cyber attacks. Boutique cyber security firm Bishop Fox disclosed its findings in a 53-page report that was attached to a legal brief filed on Monday in U.S. district court in Minnesota on behalf of the short-sellers, who hired the firm to perform the work as they defend themselves in a lawsuit filed by St.Jude. A representative for St. Jude was not immediately available for comment. St. Jude filed the suit on Sept. 7 against Muddy Waters, cyber research firm MedSec Holdings and individuals affiliated with those companies. The suit accused the group of intentionally disseminating false information about St. Jude heart devices to manipulate its stock price, which fell 5 percent on the day they revealed their claims. The defendants said in a filing released on Monday that the lawsuit is without merit, reiterating their claim that St. Jude Medical’s heart devices have “significant security vulnerabilities.” The report from Bishop Fox said the firm was able to validate those claims. “I found that Muddy Waters’ and MedSec’s statements regarding security issues in the St. JudeMedical implant ecosystem were, by and large, accurate,” Bishop Fox Partner Carl Livitt said in an introduction to the report. The report said that the wireless communications protocol used in St. Jude cardiac devices is vulnerable to hacking, making it possible for hackers to convert the company’s [email protected] patient monitoring devices into “weapons” that can cause cardiac implants to stop providing care and deliver shocks to patients. Bishop Fox tested the attacks from 10 feet (3 meters) away, but said that might be extended to 45 feet (13.7 meters) with an antenna, or 100 feet (30.5 meters) with a transmitting device known as a software defined radio.  (Reporting by Jim Finkle; Editing by Will Dunham) -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

19 октября, 22:14

Abbott Labs (ABT) Beats on Q3 Earnings, Narrows 2016 View

Abbott Labs (ABT) reported third-quarter 2016 earnings of 59 cents per share, beating the Zacks Consensus Estimate of a loss of 58 cents.

19 октября, 17:21

St. Jude Medical (STJ) Misses Q3 Earnings, Withdraws View

St. Jude Medical Inc. (STJ) reported adjusted earnings of 99 cents per share which came in below the Zacks Consensus Estimate of $1.01, but increased 2.1% on a year-over-year basis.

19 октября, 15:40

St. Jude Medical's (STJ) Q3 Earnings Miss, Sales In-line

St. Jude???s adjusted earnings of 99 cents per share were lower than the Zacks Consensus Estimate of $1.01.

Выбор редакции
Выбор редакции
18 октября, 15:03

Abbott Labs, St. Jude Medical to sell assets to Terumo for $1.1 bln

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

18 октября, 13:42

Medical Device Q3 Earnings Queued Up for Oct 18: STJ & BABY

Here we take a sneak peek into two major medical device companies lined up to report their Q3 results on Oct 18, before the opening bell.

17 октября, 16:19

St. Jude Medical (STJ) Q3 Earnings: What's in the Cards?

St. Jude Medical Inc. (STJ) is set to report third-quarter 2016 earnings results on Oct 19.

14 октября, 16:31

St. Jude (STJ) Launches PressureWire X After FDA Clearance

St. Jude Medical, Inc. (STJ) recently announced that it has launched the PressureWire X Guidewire fractional flow reserve measurement system following the receipt of the U.S. clearance.

Выбор редакции
11 октября, 16:35

Two deaths spark recall of St. Jude heart devices

(Reuters) - St. Jude Medical Inc on Tuesday said it would recall some of its 400,000 implanted heart devices due to risk of premature battery depletion, a condition linked to two deaths in Europe.

11 октября, 16:10

St. Jude (STJ) Launches EnSite Mapping System in Europe

St. Jude Medical, Inc. (STJ) recently announced that it has launched its EnSite Precision cardiac mapping system and new Sensor Enabled tools in Europe.

07 октября, 15:15

St. Jude Medical (STJ) Announces US Launch of DBS System

St. Jude Medical, Inc. (STJ) recently announced the U.S. FDA approval and first implant of its St. Jude Medical Infinity Deep Brain Stimulation (DBS) system.